PMGC HOLDINGS INC. Cash Provided by (Used in) Operating Activities, Discontinued Operations
PMGC HOLDINGS INC. (ELAB) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of -$131.33 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2026-08-14
- PMGC HOLDINGS INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2025-12-31 was $21.74K.
- PMGC HOLDINGS INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2025-09-30 was $21.70K.
- PMGC HOLDINGS INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2025-06-30 was $17.14K.
- PMGC HOLDINGS INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2025-03-31 was -$191.90K.
- PMGC HOLDINGS INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2025 was -$131.33K.
- PMGC HOLDINGS INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2024 was -$2.69M.
- PMGC HOLDINGS INC. cash provided by (used in) operating activities, discontinued operations for fiscal 2023 was -$2.44M.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 12 month |
|---|---|---|---|---|
| 2025-12-31 | $21.74K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $43.44K derived: sum of 2 quarters · filed 2026-03-30 | $60.57K derived: sum of 3 quarters · filed 2026-08-14 | -$131.33K 10-K · filed 2026-03-30 |
| 2025-09-30 | $21.70K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $38.83K derived: sum of 2 quarters · filed 2026-08-14 | -$153.07K 10-Q · filed 2025-11-14 | -$597.74K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $17.14K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | -$174.77K 10-Q · filed 2026-08-14 | -$619.43K derived: sum of 3 quarters · filed 2026-08-14 | -$948.24K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | -$191.90K 10-Q · filed 2026-05-15 | -$636.57K derived: sum of 2 quarters · filed 2026-05-15 | -$965.37K derived: sum of 3 quarters · filed 2026-05-15 | -$1.44M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | -$444.67K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | -$773.47K derived: sum of 2 quarters · filed 2026-03-30 | -$1.25M derived: sum of 3 quarters · filed 2026-03-30 | -$2.69M 10-K · filed 2026-03-30 |
| 2024-09-30 | -$328.81K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$807.24K derived: sum of 2 quarters · filed 2025-11-14 | -$2.24M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | -$478.44K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | -$1.91M 10-Q · filed 2025-08-13 | ||
| 2024-03-31 | -$1.43M 10-Q · filed 2025-05-14 | |||
| 2023-12-31 | -$2.44M 10-K · filed 2025-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |